Kevin Blas
About
Kevin Blas is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Surgery.
According to data from OpenAlex, Kevin Blas has authored 24 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 14 papers in Radiation and 5 papers in Surgery. Recurrent topics in Kevin Blas's work include Prostate Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (14 papers) and Prostate Cancer Treatment and Research (12 papers). Kevin Blas is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Advanced Radiotherapy Techniques (14 papers) and Prostate Cancer Treatment and Research (12 papers). Kevin Blas collaborates with scholars based in United States, Australia and Taiwan. Kevin Blas's co-authors include Schuyler Halverson, Daniel A. Hamstra, Howard M. Sandler, Felix Y. Feng, Karin Olson, Sean Vance, Laura E. Phelps, Felix Y. Feng, Matthew H. Stenmark and Aaron Sabolch and has published in prestigious journals such as Journal of Clinical Oncology, Journal of neurosurgery and International Journal of Radiation Oncology*Biology*Physics.
In The Last Decade
Kevin Blas
24 papers receiving 399 citations
Peers
Kevin Blas
Priyamvada Maitre India
R.O. Mirimanoff Switzerland
Stephen M. Eulau United States
Archi Agarwal India
M. Santoro United States
Vahan Kassabian United States
O. Gilliot France
Gianluca Mortellaro Italy
Matteo Augugliaro Italy
Keisuke Tsuchida Japan
Citations per year, relative to Kevin Blas Kevin Blas (= 1×)
peers
Priyamvada Maitre
Countries citing papers authored by Kevin Blas
Since
Specialization
Citations
This map shows the geographic impact of Kevin Blas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Blas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Blas more than expected).
Fields of papers citing papers by Kevin Blas
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kevin Blas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Blas. The network helps show where Kevin Blas may publish in the future.
Co-authorship network of co-authors of Kevin Blas
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Blas. A scholar is included among the top collaborators of Kevin Blas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Blas. Kevin Blas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
David, John, et al.. (2019). 18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation. PMC.
2.
David, John, et al.. (2019). 18F-FDG PET Predicts Hematologic Toxicity in Patients with Locally Advanced Anal Cancer Treated With Chemoradiation. Advances in Radiation Oncology. 4(4). 613–622.
3.
Blas, Kevin, et al.. (2018). Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer. Brachytherapy. 17(6). 852–857.
4.
Blas, Kevin, Thomas G. Wilson, Nathan Tonlaar, et al.. (2018). Dual blockade of PI3K and MEK in combination with radiation in head and neck cancer. Clinical and Translational Radiation Oncology. 11. 1–10.
5.
Mehta, Gautam U., Georgios A. Zenonos, Mohana Rao Patibandla, et al.. (2017). 362 Outcomes of Stereotactic Radiosurgery for Foramen Magnum Meningiomas. Neurosurgery. 64(CN_suppl_1). 284–284.
6.
Li, Quanlin, et al.. (2017). FDG-PET Correlation With Active Bone Marrow and Leukopenia during Chemoradiation for Anal Cancer. International Journal of Radiation Oncology*Biology*Physics. 99(2). E142–E143.
7.
Mehta, Gautam U., Georgios A. Zenonos, Mohana Rao Patibandla, et al.. (2017). Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study. Journal of neurosurgery. 129(2). 383–389.
8.
Dilworth, J.T., et al.. (2016). Left Anterior Descending Artery Avoidance for Patients Receiving Breast Irradiation. International Journal of Radiation Oncology*Biology*Physics. 96(2). E31–E31.
9.
Blas, Kevin, Nathan Tonlaar, Brandon Stone, et al.. (2015). A Matched Comparison of High-Risk Prostate Cancer Patients Treated With Dose-Escalated, Image Guided Adaptive External Beam Radiation Therapy (EBRT) Versus Pelvic EBRT Plus High-Dose-Rate Brachytherapy Boost. International Journal of Radiation Oncology*Biology*Physics. 93(3). S121–S122.
10.
Feng, Felix Y., Kevin Blas, Karin Olson, et al.. (2013). Retrospective Evaluation Reveals That Long-term Androgen Deprivation Therapy Improves Cause-Specific and Overall Survival in the Setting of Dose-Escalated Radiation for High-Risk Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 86(1). 64–71.
11.
Hamstra, Daniel A., Dale W. Litzenberg, Will Jackson, et al.. (2012). Age and Comorbid Illness Are Associated With Late Rectal Toxicity Following Dose-Escalated Radiation Therapy for Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 85(5). 1246–1253.
12.
Murgić, Jure, Matthew H. Stenmark, Schuyler Halverson, et al.. (2012). The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer. Radiation Oncology. 7(1). 127–127.
13.
Stenmark, Matthew H., Kevin Blas, Schuyler Halverson, et al.. (2011). Continued Benefit to Androgen Deprivation Therapy for Prostate Cancer Patients Treated With Dose-Escalated Radiation Therapy Across Multiple Definitions of High-Risk Disease. International Journal of Radiation Oncology*Biology*Physics. 81(4). e335–e344.
14.
Halverson, Schuyler, Matthew J. Schipper, Kevin Blas, et al.. (2011). The Cancer of the Prostate Risk Assessment (CAPRA) in patients treated with external beam radiation therapy: Evaluation and optimization in patients at higher risk of relapse. Radiotherapy and Oncology. 101(3). 513–520.
15.
Sabolch, Aaron, Felix Y. Feng, Stephanie Daignault‐Newton, et al.. (2011). Gleason Pattern 5 Is the Greatest Risk Factor for Clinical Failure and Death From Prostate Cancer After Dose-Escalated Radiation Therapy and Hormonal Ablation. International Journal of Radiation Oncology*Biology*Physics. 81(4). e351–e360.
16.
Feng, Felix Y., Yushen Qian, Schuyler Halverson, et al.. (2011). Perineural Invasion Predicts Increased Recurrence, Metastasis, and Death From Prostate Cancer Following Treatment With Dose-Escalated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 81(4). e361–e367.
17.
Qian, Yushen, Felix Y. Feng, Schuyler Halverson, et al.. (2011). The Percent of Positive Biopsy Cores Improves Prediction of Prostate Cancer–Specific Death in Patients Treated With Dose-Escalated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 81(3). e135–e142.
18.
Vance, Sean, et al.. (2011). Percentage of Cancer Volume in Biopsy Cores Is Prognostic for Prostate Cancer Death and Overall Survival in Patients Treated With Dose-Escalated External Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 83(3). 940–946.
19.
Kapadia, Nirav S., Yuli Qian, Schuyler Halverson, et al.. (2011). Perineural Invasion Predicts for Increased Recurrence, Metastasis, and Death from Prostate Cancer following Treatment with Dose-Escalated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 81(2). S378–S379.
20.
Sabolch, Aaron, Felix Y. Feng, Stephanie Daignault‐Newton, et al.. (2011). Using Gleason pattern 5 to refine risk stratification for prostate cancer patients treated with dose-escalated radiotherapy and androgen-deprivation therapy.. Journal of Clinical Oncology. 29(7_suppl). 15–15.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Priyamvada Maitre Breakdown of academic impact, for papers by R.O. Mirimanoff Breakdown of academic impact, for papers by Stephen M. Eulau Breakdown of academic impact, for papers by Archi Agarwal Breakdown of academic impact, for papers by M. Santoro Breakdown of academic impact, for papers by Vahan Kassabian Breakdown of academic impact, for papers by O. Gilliot Breakdown of academic impact, for papers by Gianluca Mortellaro Breakdown of academic impact, for papers by Matteo Augugliaro Breakdown of academic impact, for papers by Keisuke Tsuchida